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Tuberculosis 2: Pathophysiology and 
microbiology of pulmonary tuberculosis
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Pathophysiology
Inhalation of  Mycobacterium tuberculosis leads to one of  
four possible outcomes:
• Immediate clearance of  the organism
• Latent infection
• The onset of  active disease (primary disease)
• Active disease many years later (reactivation  
 disease).
Among individuals with latent infection, and no 
underlying medical problems, reactivation disease occurs 
in 5 to 10 percent of  cases [1]. The risk of  reactivation 
is markedly increased in patients with HIV [2]. These 
outcomes are determined by the interplay of  factors 
attributable to both the organism and the host.
Primary disease
Among the approximately 10 per cent of  infected 
individuals who develop active disease, about half  will do 
so within the first two to three years and are described as 
developing rapidly progressive or primary disease.
The tubercle bacilli establish infection in the lungs after 
they are carried in droplets small enough (5 to 10 microns) 
to reach the alveolar spaces. If  the defense system of  the 
host fails to eliminate the infection, the bacilli proliferate 
inside alveolar macrophages and eventually kill the 
cells. The infected macrophages produce cytokines and 
chemokines that attract other phagocytic cells, including 
monocytes, other alveolar macrophages and neutrophils, 
which eventually form a nodular granulomatous structure 
called the tubercle. If  the bacterial replication is not 
controlled, the tubercle enlarges and the bacilli enter local 
draining lymph nodes. This leads to lymphadenopathy, 
a characteristic clinical manifestation of  primary 
tuberculosis (TB). The lesion produced by the expansion 
of  the tubercle into the lung parenchyma and lymph node 
involvement is called the Ghon complex. Bacteremia may 
accompany initial infection.
The bacilli continue to proliferate until an effective 
cell-mediated immune (CMI) response develops, usually 
two to six weeks after infection. Failure by the host to 
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mount an effective CMI response and tissue repair leads to 
progressive destruction of  the lung. Tumour necrosis factor 
(TNF)-alpha, reactive oxygen and nitrogen intermediates 
and the contents of  cytotoxic cells (granzymes, perforin) 
may all contribute to the development of  caseating 
necrosis that characterize a tuberculous lesion.
Unchecked bacterial growth may lead to 
haematogenous spread of  bacilli to produce disseminated 
TB. Disseminated disease with lesions resembling millet 
seeds is termed miliary TB. Bacilli can also spread by 
erosion of  the caseating lesions into the lung airways -and 
the host becomes infectious to others. In the absence of  
treatment, death ensues in 80 per cent of  cases [3]. The 
remaining patients develop chronic disease or recover. 
Chronic disease is characterized by repeated episodes of  
healing by fibrotic changes around the lesions and tissue 
breakdown. Complete spontaneous eradication of  the 
bacilli is rare.
reactivation disease
Reactivation TB results from proliferation of  a 
previously dormant bacterium seeded at the time of  the 
primary infection. Among individuals with latent infection 
and no underlying medical problems, reactivation disease 
occurs in 5 to 10 per cent [1]. Immunosuppression is 
associated with reactivation TB, although it is not clear 
what specific host factors maintain the infection in a latent 
state and what triggers the latent infection to become 
overt.  See previous article [4] for immunosuppressive 
conditions associated with reactivation TB.   The disease 
process in reactivation TB tends to be localized (in 
contrast to primary disease): there is little regional lymph 
node involvement and less caseation. The lesion typically 
occurs at the lung apices, and disseminated disease is 
unusual unless the host is severely immunosuppressed. It 
is generally believed that successfully contained latent TB 
confers protection against subsequent TB exposure [5]
Microbiology
M.tuberculosis (MTB) belongs to the genus Mycobacterium 
that includes more than 80 other species. Tuberculosis 
(TB) is defined as a disease caused by members of  the M. 
tuberculosis complex, which includes the tubercle bacillus 
(M. tuberculosis), M. bovis, M. africanum, M. microti, M. 
canetti, M. caprae and M. pinnipedi [6].  
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Cell envelope: The mycobacterial cell envelope is 
composed of  a core of  three macromolecules covalently 
linked to each other (peptidoglycan, arabinogalactan, and 
mycolic acids) and a lipopolysaccharide, lipoarabinomannan 
(LAM), which is thought to be anchored to the plasma 
membrane [7]. 
Staining characteristics: The cell wall components 
give mycobacteria their characteristic staining properties. 
The organism stains positive with Gram’s stain. The 
mycolic acid structure confers the ability to resist destaining 
by acid alcohol after being stained by certain aniline dyes, 
leading to the term acid fast bacillus (AFB). Microscopy 
to detect AFB (using Ziehl-Neelsen or Kinyoun stain) 
is the most commonly used procedure to diagnose TB; 
a specimen must contain at least 10 [5] colony forming 
units (CFU)/mL to yield a positive smear [8]. Microscopy 
of  specimens stained with a fluorochrome dye (such as 
auramine O) provides an easier, more efficient and more 
sensitive alternative. However, microscopic detection of  
mycobacteria does not distinguish M. tuberculosis from 
non-tuberculous mycobacteria.
Growth characteristics: MTB are aerobes. Their 
reproduction is enhanced by the presence of  5-10% CO2 
in the atmosphere. They are grown on culture media with 
high lipid content, e.g. Lowenstein-Jensen (LJ) medium. 
The generation time of  TB is approximately 12-18 hours, 
so that cultures must be incubated for three to six weeks at 
370C until proliferation becomes microscopically visible. 
[9] Broth-based culture systems to improve the speed and 
sensitivity of  detection have been developed [10]. In AFB 
smear-positive specimens, the BACTEC system can detect 
M. tuberculosis in approximately eight days (compared to 
approximately 14 days for smear-negative specimens 
[11,12].
Drug sensitivity testing: Drug sensitivity testing is 
increasingly important with the emergence of  increasingly 
more resistant M. tuberculosis isolates. In addition to the 
conventional methods to test M. tuberculosis drug sensitivity, 
methods that rely on automated systems and PCR-based 
tests have been developed [13,14]. The microscopic 
observation drug sensitivity (MODS) test is another liquid 
culture drug-sensitivity test based on observation of  M. 
tuberculosis growth in liquid broth medium containing a 
test drug.  In an evaluation of  3,760 sputa samples using 
MODS, automated MB/BacT system, and Löwenstein-
Jensen culture, sensitivity was 98, 89, and 84 percent 
respectively and the median time to the test results was 
7, 22, and 68 days respectively [15]. The Xpert MTB/RIF 
is an integrated system that combines sample preparation 
in a modular cartridge system and real-time PCR. In 2010 
Figure 1. Pathophysiology of  tuberculosis
Reproduced with permission from ‘Immune responses to tuberculosis in developing countries: implications for new vaccines’ by Graham A. W. Rook, 
Keertan Dheda, Alimuddin Zumla in Nature Reviews Immunology published by Nature Publishing Group Aug 1, 2005
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this technique was recommended by the WHO to be used 
in place of  traditional smear microscopy for the diagnosis 
of  drug-resistant TB or TB in HIV-infected patients [16]. 
This test has been shown to have a sensitivity of  greater 
than 98 per cent in sputum smear-positive TB cases and 75 
to 90 per cent in smear-negative TB cases. The sensitivity 
in the detection of  rifampicin resistant MTB exceeded 
97 per cent, while specificity ranged 98 to 100 per cent. 
The test can yield results in less than two hour [17-19]. 
Here rifampicin resistance is assessed as a surrogate for 
multidrug resistant MTB.
Conclusion
South Sudan faces huge challenges in controlling 
tuberculosis. This is partly due to a limited laboratory 
network and lack of  a tuberculosis reference laboratory 
(author’s observation).
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